Recall Update (3 posts)

Manufacturer Removes Remaining Stocks of Trasylol
Background: On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding.
Bayer HealthCare Pharmaceuticals Inc. has notified the FDA that the company will begin removing the remaining Trasylol stock from the U.S. market, most of which is in warehouses and hospital or physician’s stock. The FDA will work with Bayer to ensure a smooth and complete process...

Medtronic Initiates Voluntary Field Actions for Selected Heparin-Coated Products Used During Cardiopulmonary Bypass
Medtronic, Inc. today (May 7, 2008) announced that it is initiating a voluntary and precautionary recall of selected products featuring the Carmeda BioActive surface. The affected devices are disposable products used during cardiopulmonary bypass (CPB) for heart...

Air Pistols That Can Fire Unexpectedly Are Recalled by Umarex USA
The U.S. Consumer Product Safety Commission, in cooperation with the firm named below today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed.
Name of Product: Air Pistols
Units: About 7,250
Distributor: Umarex USA Inc., of Fort Smith, Ark.
Manufacturer: DianaWerk GmbH & Co., of Rastatt, Germany
Hazard: The air pistols can accidentally discharge, posing a risk of serious injury...